User Tools

Site Tools


microvascular_decompression_for_trigeminal_neuralgia

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
microvascular_decompression_for_trigeminal_neuralgia [2020/02/05 21:07]
administrador [Systematic Review and Meta-Analysis]
microvascular_decompression_for_trigeminal_neuralgia [2020/02/05 21:08] (current)
administrador [Systematic Review and Meta-Analysis]
Line 38: Line 38:
 Outcome data were analyzed for 3897 patients from 46 studies (7 prospective, 39 retrospective). Overall, 76.0% of patients achieved pain freedom after MVD with a mean follow-up of 1.7 ± 1.3 (standard deviation) yr. Predictors of pain freedom on meta-analysis using random effects models included (1) disease duration ≤5 yr (OR = 2.06, 95% CI = 1.08-3.95); (2) arterial compression over venous or other (OR = 3.35, 95% CI = 1.91-5.88); (3) superior cerebellar artery involvement (OR = 2.02, 95% CI = 1.02-4.03), and (4) type 1 Burchiel classification (OR = 2.49, 95% CI = 1.32-4.67). Outcome data were analyzed for 3897 patients from 46 studies (7 prospective, 39 retrospective). Overall, 76.0% of patients achieved pain freedom after MVD with a mean follow-up of 1.7 ± 1.3 (standard deviation) yr. Predictors of pain freedom on meta-analysis using random effects models included (1) disease duration ≤5 yr (OR = 2.06, 95% CI = 1.08-3.95); (2) arterial compression over venous or other (OR = 3.35, 95% CI = 1.91-5.88); (3) superior cerebellar artery involvement (OR = 2.02, 95% CI = 1.02-4.03), and (4) type 1 Burchiel classification (OR = 2.49, 95% CI = 1.32-4.67).
  
-Approximately three-quarters of patients with drug-resistant TN achieve pain freedom after MVD. Shorter disease duration, arterial compression, and type 1 Burchiel classification may predict a more favorable outcome. These results may improve patient selection and provider expectations+Approximately three-quarters of patients with drug-resistant TN achieve pain freedom after MVD. Shorter disease duration, arterial compression, and type 1 [[Burchiel classification]] may predict a more favorable outcome. These results may improve patient selection and provider expectations
 ((Holste K, Chan AY, Rolston JD, Englot DJ. Pain Outcomes Following ((Holste K, Chan AY, Rolston JD, Englot DJ. Pain Outcomes Following
 Microvascular Decompression for Drug-Resistant Trigeminal Neuralgia: A Systematic Microvascular Decompression for Drug-Resistant Trigeminal Neuralgia: A Systematic
microvascular_decompression_for_trigeminal_neuralgia.txt · Last modified: 2020/02/05 21:08 by administrador